Analysis of IgG4-positive clones in affected organs of IgG4-related disease by 覚知 泰志 & Kakuchi Yasushi
  2 
Analysis of IgG4-positive clones in affected organs of IgG4-related disease 
 
Yasushi Kakuchi1, Kazunori Yamada1, Kiyoaki Ito1, Satoshi Hara1, Hiroshi Fujii1, Masakazu 
Yamagishi2, Mitsuhiro Kawano1* 
 
1Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate 
School of Medicine, 920-0942, Japan 
 
2Division of Cardiology, Department of Internal Medicine, Kanazawa University Graduate School 
of Medicine, 920-0942, Japan 
 
*Correspondence:  Mitsuhiro Kawano, sk33166@gmail.com 
 








  3 
Abstract 
Objective. We investigated class switch reaction (CSR) in affected organs and evaluated whether 
the same or genetically related clones exist in IgG4-RD. 
Methods. We studied three patients with IgG4-RD. Total cellular RNA was extracted from 
salivary glands and peripheral blood, and lung tissue. Activation-induced cytidine deaminase 
(AID) and immunoglobulin heavy chain third complementarity determining region (IgVH-CDR3) 
of IgM and IgG4 were detected by reverse transcription polymerase chain reaction. We analyzed 
the clonal relationship of infiltrating IgG4-positive cells, as compared with IgM. We determined 
the existence of common clones among organs and patients. 
Result. AID was expressed in salivary glands of all patients and lung tissue in one. Closely 
related IgVH-CDR3 sequences in infiltrating IgG4-positive cells were detected in salivary glands 
and lung tissue. Identical IgVH-CDR3 sequence between IgM and IgG4 in salivary glands was 
detected in one patient, indicating CSR in salivary glands. Identical IgVH-CDR3 sequences of 
IgG4-positive cells were detected between salivary glands and peripheral blood in two patients. 
Four identical sequences of IgVH-CDR3 existed between patients. Interestingly, one of the four 
sequences was detected in all patients. 
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Introduction 
IgG4-related disease (IgG4-RD) is a clinical entity characterized by high serum IgG4 
concentrations and extensive IgG4-positive plasma cell infiltration into involved organs [1, 2]. 
IgG4-RD shares some histopathological features in involved organs and affects multiple organs, 
notably pancreas, lacrimal and/or salivary glands, lung, kidney, retroperitoneum, aorta, lymph 
nodes and skin [3-13]. A dramatic responsiveness to corticosteroid is a notable feature, while the 
etiology remains unclear.  
Class switch recombination (CSR) and somatic hypermutation (SHM) are found in 
germinal center (GC)-like structures. Activation-induced cytidine deaminase (AID) is required 
for both CSR and SHM [14, 15]. AID is expressed not only in secondary lymphoid organs but also 
in local tissues in salivary glands of Sjögren syndrome (SS) [16-18], nasal mucosa of allergic 
rhinitis [19, 20] and bronchial asthma[21]. We previously showed AID expression in lacrimal 
gland of IgG4-related sialadenitis and/or dacryoadenitis and that SHM of IgG4-positive plasma 
cells might occur in lacrimal glands suggesting that immunoglobulin production in IgG4-related 
dacryoadenitis is antigen-driven [22]. However, it remains unclear whether polyclonal 
expansions of IgG4-positive cells and CSR in affected organs are common features of IgG4-RD. 
Immunoglobulin has three complementarity determining regions (CDRs) that determine 
the specificity for antigen, and CDR3 plays the most important role. Therefore, the antibodies 
that have the same CDR3 sequence are surmised to recognize the same antigen. Previous studies 
demonstrated that IgG4 plays an inhibitory role in allergic rhinitis [23, 24]. Conversely, 
pathogenic antibodies of pemphigus were reported to belong to IgG4 subclass [25]. The 
pathological and immunological roles of IgG4 antibody in IgG4-RD remain unclear, and studies 
focusing on these issues are needed.  
The aims of the present study are: 1) to investigate CSR in affected organs, and 2) to 
evaluate whether the same or genetically related clones exist in patients with IgG4-RD. For the 
purpose, we first analyzed the expression of AID to determine CSR and SHM in salivary glands 
and lung, and then compared the clonal relationship of infiltrating IgM and IgG4-positive cells. 
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Materials and methods 
 
Patient Profiles 
We enrolled three patients with IgG4-RD, the diagnosis of which was made by a 
specialist of IgG4-RD, based on the presence of tumefactive lesions and typical histopathological 
findings with copious IgG4-positive plasma cell infiltration into the affected organs (Figure 1). Two 
patients (Patient 1 and 2) had definite and one (Patient 3) had probable disease according to the 
comprehensive diagnostic criteria for IgG4-RD [26]. Patients’ profiles are shown in Table 1. 
Salivary glands, lung tissue and peripheral blood samples were obtained from these patients.  
This study received institutional ethics board approval, and informed consent for all data 
and samples was obtained from each patient. The research was conducted in compliance with the 
Declaration of Helsinki. 
	  
Histology and immunohistochemistry 
 Pathology specimens fixed in 20% formalin and embedded in paraffin were retrieved from 
the surgical pathology files of the Pathology Section of Kanazawa University Hospital, Kanazawa, 
Japan. Hematoxylin and eosin (HE) staining and IgG4 immunostaining were performed. In the 
latter, a mouse monoclonal antibody to IgG4 (1: 1000, ZYMED Laboratory, San Francisco, CA, 
USA) was used.  
 
Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
Total cellular RNA was extracted from salivary glands, lung tissue and peripheral blood 
using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). The cDNA was synthesized using the Oligo 
d(T)16 (Applied Biosystems, CA, USA). We performed nested reverse RT-PCR for AID. The 
oligonucleotide sequences used are shown in Table 2. The amplification program consisted of one 
cycle of 94ºC for 10 min, followed by 30 cycles of 94ºC for 15 sec, 54ºC for 30 sec, and 72ºC for 30 sec. 
After 30 cycles all products received a final extension of 5 min at 72ºC. In the second PCR, the 
annealing temperature was 60ºC. We then performed immunoglobulin subclass-specific RT-PCR 
amplification using primers to amplify immunoglobulin Framework (FR) 3 and immunoglobulin 
subclass. The oligonucleotide sequences of immunoglobulin subclass specific reverse primers are 
shown in Table 2.  
The variable region of IgVH of IgG4 was analyzed using IgVH gene family specific 
primers and IgG4 specific primer. Primers used for IgVH gene family specific amplification were 
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previously described [27]. IgVH of IgM was analyzed using hM3 for IgM specific primer. The 
amplification program consisted of one cycle of 94ºC for 10 min, followed by 30 cycles of 94ºC for 15 
sec, 59ºC for 30 sec, 72ºC for 30 sec. After 30 cycles all products received a final extension of 5 min 
at 72ºC. Cloning of the IgVH gene PCR products was performed using TOPO TA Cloning Kit 
(Invitrogen, Carlsbad, CA, USA).  
 
Sequence analysis 
Sequences were analyzed with an automated DNA sequencer (ABI PRISM 310 Genetic 
Analyzer; Applied Biosystems). Primers for the sequence analysis were M13F, M13R or IgVH gene 
specific primers.  
 
Data analysis 
Sequences were compared with those in the IMGT/V-QUEST (http: 
//www.imgt.org/IMGT_vquest/share/textes/index.html) and compared with the IgVH-CDR3 of the 
salivary glands, lung tissue and peripheral blood cells. 
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Results 
 
Detection of AID and CSR in the affected organs 
We analyzed the expression of AID in salivary glands of the three patients and lung 
tissue of patient 2 using RT-PCR, and confirmed that AID was expressed in all of them (Figure 2a). 
These data indicated that both SHM and CSR occurred in the salivary glands and lung tissue. 
Next, we investigated the existence of identical IgVH-CDR3 in IgM and IgG4 positive cells in 
each patient to confirm CSR in the affected organs. In patient 2, two identical sequences of 
IgVH-CDR3, SGYKFGTRFAV (AGT GGC TAC AAG TTC GGC ACA CGT TTT GCC GTC), 
were found in IgM and IgG4 positive cells in salivary glands, suggesting that CSR might have 
occurred in salivary glands. 
 
Expansion of IgG4-positive cells in affected organs 
	 	 We investigated the clonality of infiltrating IgM- and IgG4-positive cells by performing 
sequence analysis of IgVH-CDR3 (Table 3). For patient 1, six dominant sequences of CDR3 were 
detected in both IgM- and IgG4-positive cells that infiltrated salivary glands. For patient 2, six 
dominant sequences of IgM and one of IgG4-CDR3 were detected in salivary glands, and eight 
dominant sequences of IgG4-CDR3 were detected in lung tissue. For patient 3, five dominant 
sequences of IgM and eleven of IgG4-CDR3 were detected in salivary glands. The appearance of 
dominant sequences of IgM and IgG4-CDR3 may indicate that IgM- and IgG4-positive cells 
infiltrating the salivary glands and lung tissue in the patient with IgG4-RD showed dominant 
expansion. 
 
Detection of identical or genetically related clones between organs and patients 
We investigated the identical or genetically related IgG4 positive clones between salivary 
glands, lung tissue and peripheral blood. We found that the identical sequence of IgG4-CDR3, 
HLRFRGKAAPFDI in patient 1 and EFLN in patient 3, respectively, existed in salivary glands 
and peripheral blood (Table 4a). These results support our previous report that showed the 
existence of identical or genetically related clones between lacrimal glands and peripheral blood in 
a patient with IgG4-RD [22]. We also found that genetically related clones that had three different 
amino acid sequences of IgG4-CDR3 existed in salivary glands and lung tissue in patient 2 (Table 
4a).  
 Next, we investigated the existence of an identical sequence of IgVH-CDR3 in the three 
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patients to clarify whether identical or clonally related clones are shared between them. In the 
IgG4-CDR3, four identical sequences were identified: NIAAIGTGYWYFDL in peripheral blood of 
patient 1, salivary glands of patient 3, and lung tissue of patient 2; VAIVVVPAGKGAFDI in lung 
tissue of patient 2, and in salivary glands of patient 3; DRAQY in salivary glands of patient 1 and 
3; and HLRFRGKAAPFDI in salivary glands of patient 1 and 3, and in peripheral blood of patient 
1 (Table 4b).  
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Discussion  
In this study, we analyzed the repertoires of IgG4-positive or IgM-positive cell 
populations in the inflamed organs or peripheral blood in three patients with IgG4-RD, and 
obtained the identical sequences of IgVH-CDR3 between IgG4 and IgM-positive cells in salivary 
gland in patient 2. We also found four kinds of IgG4-positive clone that shared an identical or 
closely related IgVH-CDR3 sequence between the patients (Figure 3). In particular, an identical 
IgVH-CDR3 sequence, NIAAIGTGYWYFDL, was detected in the peripheral blood in patient 1 and 
two inflamed tissues (lung in patient 2, and salivary gland in patient 3). This clone showed 
marked accumulation in the minor salivary gland of patient 3 (12 identical clones out of the 47 
clones analyzed). The minor salivary gland of patient 3 was suspected to be an early lesion of 
IgG4-RD, because of the presence of only one germinal center-like structure with scattered 
IgG4-positive plasma cells. A dominant IgG4-positive clone might be easily detected.  
        AID and two identical CDR3 sequences, SGYKFGTRFAV, between IgM and IgG4 were 
detected by sequencing IgVH-CDR3 in salivary glands of IgG4-RD. The expression of AID is 
required for the process of CSR and SHM [14]. We detected AID in lacrimal glands [22] and 
salivary glands in patients with IgG4-RD. These data indicated that CSR may occur in the organs 
affected by IgG4-RD. Previous studies on allergic rhinitis [19,20] and bronchial asthma [21] 
showed that isotype switching occurred at affected sites. Snow et al described that IgE related 
clones were matured in bronchial mucosa of atopic asthma [21]. Our data might reveal that 
isotype switching from IgM to IgG4 occurred in salivary glands of IgG4-RD. 
   We demonstrate the possible existence of a common antigen in IgG4-RD patients because the 
same CDR3 sequence was detected in 3 patients with IgG4-RD. Recently, Wallace et al 
demonstrated that circulating plasmablasts were likely to be a useful biomarker of disease activity 
in IgG4-RD [28]. In addition, a pathogenic role for plasmablasts in IgG4-RD was also speculated. 
Under these conditions, however, the relationship between circulating plasmablasts and tissue 
infiltrating IgG4-producing cells has not been sufficiently clarified. We previously showed common 
clones in IgG4-positive cells between lacrimal glands and peripheral blood [22]. Maillette de Buy 
Wenniger et al also clearly showed that the dominantly expanded clones were identical in both 
peripheral blood and the duodenal papilla (affected tissue) in patients with IgG4-associated 
cholangitis using next-generation sequencing technique [29]. Mattoo et al also showed that 
increased plasmablasts in the peripheral blood of 5 patients with IgG4-RD had a high degree of 
somatic hypermutation [30]. These findings also suggest that hypergammaglobulinemia and 
increased serum IgG4 levels are not merely induced by non-specific polyclonal gammaglobulinemic 
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stimulation but by an antigen-driven mechanism. 
   Although recent studies indicate that increased serum IgG4 levels result from an 
antigen-driven mechanism, it is unclear whether extrinsic or intrinsic antigens elicit increased 
production of IgG4 in IgG4-RD. Okazaki et al showed that antibodies against autoantigens such 
as pancreatic trypsin inhibitor, lactoferrin, and carbonic anhydrase exist in the sera of patients 
with autoimmune pancreatitis [31], suggesting that IgG4-RD is an autoimmune disease. However, 
they did not confirm that the IgG subclass of those antigens was IgG4. In contrast, Frulloni et 
al demonstrated that the antibodies against an amino acid sequence of plasminogen-binding 
protein of Helicobacter pylori were frequently found in the sera of autoimmune pancreatitis, 
although this interesting finding has not yet been confirmed by others [32]. Similarly, we 
previously showed the possibility of involvement of Mycobacterium tuberculosis in the 
pathogenesis of IgG4-RD [33]. These findings suggest that some kind of unusual immune reaction 
to some microorganisms might have a causative role in the disease process. Furthermore, since 
IgG4-RD is sometimes associated with allergic predisposition, allergic rhinitis and bronchial 
asthma, involvement of extrinsic antigens in the pathogenesis of IgG4-RD is also plausible.  
   In summary, our results suggest the existence of common antigen(s) shared by patients with 
IgG4-RD, although the antigens are still unknown. Further studies will be needed to clarify the 
key antigen that is the causative agent of IgG4-RD. 
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Table 1. Profile of patients with IgG4-related disease 
 
Average age was 64 years. Elevated IgG4 was seen in patient 1 and 2. Elevated IgE was seen in 
patient 1 and 3. Decreased complement was seen in patient 1. Anti-nuclear antibody (ANA), 
anti-Sjögren’s syndrome A antibody (SSA) and anti-Sjögren’s syndrome B antibody (SSB) were 
negative in all patients. LG: lacrimal gland, SG: salivary glands, P: pancreas, LT: lung tissue 
 
Table 2. Sequences of primers 
 
Aid F1 5’-GAGGCAAGAAGACACTCTGG-3’ 
Aid R1 5’-GTGACATTCCTGGAAGTTGC-3’ 
Aid F2 5’-TAGACCCTGGCCGCTGCTACC-3’  
Aid R2 5’-CAAAAGGATGCGCCGAAGCTGTCTGGAG-3’ 
FR3 5’-CTGAGGACACGGCCGTGTATTACTG-3’ 
IgG4 5’-AACTCAGGTGCTGGGCATGATGGGGGACCATA-3’ 
hM3  5’-GGAAAAGGGTTGGGGCGGAT-3’ 
 
AID, activation-induced cytidine deaminase; IgG, immunoglobulin G. 









1 79 F 4350 1770 3319 5 
LG, SG, 
P 
SG (88.5) SG 




3 50 F 1078 61 1621 58 SG SG (67.2) SG 
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IgM-SG (n=32) Number of 
sequences 
G  Y  Y  G  S  G  S  Y  Y  N  V  R  A  F  D  T 8 
D  Y  Y  S  R  M  D  V 3 
A  G  Y  S  T  E  S  L  A  F  E  I  2 
G  L  N  C  G  S  I  E  C  Y  G  A  F  D  Y 2 
K  R  M  T  G  I  A  F  D  I 2 
V  G  L  V  G  V  T  G  R  S  R  A  F  D  I 2 
IgG4-SG (n=32)  
D  G  P  D  S  S  G  Y  V  D  Y 6 
D  V  A  V  G  G  C  Y  D  S 5 
D  L  L  A  L  A  A  D  G  I  D  Y 3 
N  I  Y  N  N  N  W  Y  T  G  R  L  G  A  F  D  V 3 
D  G  E  M  P  A  A  Y  H  Y  Y  G  M  D  V 2 




IgG4-PB (n=19) Number of 
Sequences 
D  I  T  I  D  V  V  E  I  D  H 4 
L  Y  S  D  S  S  S  L  G  T  K  T 2 





IgM-SG (n=52) Number of 
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sequences 
R  L  A  S  N  S  Y  Y  M  D  V 10 
G  D  Y  C  S  S  T  S  C  S  N  I  H  Y  Y  Y  M  D  V 4 
A  D  S  D  Y  Y  Y  L  A  L  S  H 2 
D  P  D  Y  Y  V  N  W  F  D  P 2 
H  P  L  T  N  S  A  Y  F  D  S  2 
S  G  R  R  G  F  G  E  L  G  F  K  W  F  D  P 2 
IgG4-SG (n=47)  
S  G  T  Y  P  N  R  F  Q  V  P  F  S  V 2 
 
Lung tissue 
IgG4-LT (n=51) Number of 
Sequences 
G  Y  Y  Y  D  I  S  G  Y  Y  V  F  Q  H 5 
V  A  I  V  V  V  P  A  G  K  G  A  F  D  I 3 
V  R  G  Y  F  D  S  G  R  Q  D  M  D  V  3 
A  T  V  S  W  F  G  P  Q  N  S  Y  F  Y  Y  M  D  V 2 
G  K  S  S  Y  Y  P  N  W  F  D  P  2 
G  V  P  A  S  G  S  Y  Y  Y  M  D  V 2 
H  V  A  L  V  P  R  Y  G  S  S  G  Y  F  D  F 2 
L  A  D  I  Y  Y  G  W  V  D  P  2 
 
Peripheral blood 
IgG4-PB (n=51) Number of 
Sequences 






IgM-SG (n-27) Number of 
sequences 
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D  N  G  H  D  I  L  T  G  N  Y  N  V  A  A  F  D  I 3 
A  A  N  R  A  F  A  F 2 
G  S  N  Y  A  F  I  2 
R  K  E  W  A  F  V  E  2 
V  H  G  A  S  G  H  Y  D  L  D  Y 2 
IgG4-SG (n=47)  
N  I  A  A  I  G  T  G  Y  W  Y  F  D  L 12 
D  F  Y  W  L  A  P  4 
D  P  A  F  D  I  4 
E  F  L  N 3 
G  T  Y  Y  Y  D  S  S  G  Y  F  Q  N  W  F  D  P 3 
H  S  G  D  I  I  T  G  I  S  E  C  G  F  D  Y 3 
D  C  G  S  N  T  W  Y  S  L  P  F  D  S 2 
D  L  A  P  K  D  L  F  Y  A  F  D  I 2 
D  P  V  A  T  F  D  K  T  G  Y  Y  Y  Y  G  M  D  V 2 
D  S  D  R  W  H  P  A  Y  F  D  Y 2 




IgG4-PB (n=42) Number of 
Sequences 
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Table 4. 
 
(a) Identical sequence analysis of IgG4-CDR3 in each patient 
 
 SG PB LT 
Patient 1 HLRFRGKAAPFDI HLRFRGKAAPFDI 
 
Patient 2 GGITIFGARDYYFMDV  
GGITIFGDQDYYYMDV 
GGITIFGDRDYYYMDV 
Patient 3 EFLN  EFLN  
Amino acid differences from the proposed germline are underlined. 
SG:  salivary glands, PB:  peripheral blood, LT:  lung tissue 
 
(b) Identical sequence analysis of IgG4-CDR3 in patients 
 
  Patient 1 Patient 2 Patient 3 
SG PB SG PB LT SG PB 
IgG4 
NIAAIGTGYWYFDL  2/32   1/51 12/47  
VAIVVVPAGKGAFDI     3/51 1/47  
DRAQY 1/32     1/47  
HLRFRGKAAPFDI 1/32 1/32    2/47  
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Figure 1  
Histopathological findings for the IgG4-RD cases  
 
 
Panels A, C, E, and G: H&E staining. Panels B, D, F, and H: IgG4 immunostaining. Panels A and 
B: lesion of patient 1. Panels C to F: Lesion of patient 2. Panels G and H: Lesion of patient 3. 
Panels A, B, C, D, G, and H: salivary glands. Panels E and F, alveolar interstitium. All images: hpf 
×400. Scale bars: 50 µm. Many IgG4-positive plasma cells were observed in Panels B, D, F, and H. 
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Figure 2  
Expression of activation-induced cytidine deaminase (AID) in salivary glands and 
lung tissue in patients with IgG4-RD.  
 
 
Lanes 1-3:  salivary glands (patient 1, 2 and 3 respectively); lane 4:  lung tissue (patient 2); lane 
5:  RAMOS cell (Burkitt’s lymphoma-derived cell line) as a positive control. The 647-bp band 
obtained using RT-PCR and the 358-bp band obtained using nested PCR corresponded to the 
AID gene. AID was expressed to varying degrees in all patients with IgG4-RD. 
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Figure3  




In the IgG4-CDR3, four identical sequences exist: NIAAIGTGYWYFDL in salivary glands of 
patient 1 and 3 and lung tissue of patient 2; VAIVVVPAGKGAFDI in lung tissue of patient 2 and 
in salivary glands of patient 3; DRAQY in salivary glands of patient 1 and 3; and 
HLRFRGKAAPFDI in salivary glands of patient 1 and 3, and in peripheral blood of patient 1. 
SG:  salivary glands, PB:  peripheral blood 
 
